Home

Basic Information

708
52
8
4.8(39)

Trade Type

Sell

Product Name

Erenumab

Manufacturer(s)

Specifications

  • Application: CGRP-receptor-targeting monoclonal antibody biosimilar candidate for migraine prevention, developed from a DMF-filed cell line.
  • Expression System: Produced in a validated mammalian cell expression system (e.g., CHO cells) under GMP-compliant biomanufacturing.
  • Purity: High-purity monomer content confirmed by SEC-HPLC/CE-SDS, consistent with the reference biologic.

Documents

GMP
Filters:
Sort by:

    No comments available.

Matched Products & Services

B2B matches based on trade type, category, specifications & price range

Similar Products & Services

Products & Services related to what you're viewing

People Also Viewed

Other products & services viewed by people who looked at this product